Minimizing the side effects of immunosuppression in kidney transplant recipients

Current Opinion in Organ Transplantation

Volumn 8, Issue 2, 2003, Pages 160-166

  Bodziak, Kenneth A ^a   Hricik, Donald E ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0042571605     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/00075200-200306000-00006     Document Type: Review

References (31)

1. Hueso M, Boyer J, Seron D, et al.: Low-dose cyclosporine and mycophenolate mofetil in renal allograft recipients with suboptimal renal function. Transplantation 1998, 66:1727-1731.
2. Houde I, Isenring P, Boucher D, et al.: Mycophenolate mofetil, an alternative to cyclosporine A for long-term immunosuppression in kidney transplantation? Transplantation 2000, 70:1251-1253.
3. Weir MR, Ward MT, Blahut SA, et al.: Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy. Kidney Int 2001, 4:1567-1573.
4. Kasiske BL, Chakkera HA, Louis TA, et al.: A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol 2000, 10:1910-1917.
5. Schrama YC, Joles JA, van Tol A, et al.: Conversion to mycophenolate mofetil in conjunction with stepwise withdrawal of cyclosporine in stable renal transplant recipients. Transplantation 2000, 69:376-383.
6. Abramowicz D, Manas D, Lao M, et al.: Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen in stable kidney transplant recipients: a randomized, controlled study. Transplantation 2002, 74:1725-1734.
7. Johnson RWG, Kreis H, Oberbauer R, et al.: Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure. Transplantation 2001, 72:777-786.
8. Gonwa TA, Hricik DE, Brinker K, et al.: Improved renal function in sirolimustreated renal transplant patients after early cyclosporine elimination. Transplantation 2002, 74:1560-1567.
9. Tran HTB, Acharya MK, McKay DB, et al.: Avoidance of cyclosporine in renal transplantation: effects of Daclizumab, mycophenolate mofetil, and steroids. J Am Soc Nephrol 2000, 11:1903-1909.
10. Vincenti F, Ramos E, Brattstrom C, et al.: Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation. Transplantation 2002, 71:1282-1287.
11. Groth CG, BAckman L, Morales JM, et al.: Sirolimus (rapamycin)-based therapy in human renal transplantation. Similar efficacy and different toxicity compared with cyclosporine. Transplantation 1999, 67:1036-1042.
12. Kreis H, Cisterne JM, Land W, et al.: Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients. Transplantation 2000, 69:1252-1260.
13. Flechner SM, Goldfarb D, Modlin C, et al.: Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine. Transplantation 2002, 74:1070-1076.
14. Hong JC, Kahan BD: Use of anti-CD25 monoclonal antibody in combination with rapamycin to eliminate cyclosporine treatment during the induction phase of immunosuppression. Transplantation 1999, 68:701-703.
15. Veenstra DL, Best JH, Hornberger J, et al.: The incidence and long-term cost of steroid-related side effects after renal transplantation. Am J Kidney Dis 1999, 33:829-839.
16. Hricik DE: Steroid-free immunosuppression in kidney transplantation: an editorial review. Am J Transplant 2002, 2:19-24.
17. Ahsan N, Hricik D, Matas A, et al. for the Steroid Withdrawal Study Group: Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil-a prospective randomized study. Transplantation 1999, 68:1865-1874.
18. Vanrenterghem Y, Lebranchu Y, Hene R, et al. for the Steroid Dosing Study Group: Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection. Transplantation 2000, 70:1352-1359.
19. Smak Gregoor PJ, de Sevaux RG, Ligtenberg G, et al.: Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy: a randomized, prospective, multicenter study. J Am Soc Nephrol 2002;13:1365-1373.
20. Mahalati K, Kahan BD: A pilot study of steroid withdrawal from kidney transplant recipients maintained on sirolimus-cyclosporine A combination therapy. Transplant Proc 2001, 33:3232-3233.
21. Boots JMM, Christiaans MHL, van Duijnhoven EM, et al.: Early steroid withdrawalin renal transplantation with tacrolimus dual therapy: a pilot study. Transplantation 2002, 74:1703-1709.
22. Swanson SJ, Hale DA, Mannon RB, et al.: Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy. Lancet 2002, 360:1662-1664.
23. Matas AJ, Ramcharan T, Paraskevas G, et al.: Rapad discontinuation of steroids in living donor kidney transplantation: a pilot study. Am J Transplant 2001, 1:278-283.
24. Kaufman DB, Baker MS, Chen X, et al.: Sequential kidney/islet transplantation using prednisone-free immunosuppression. Am J Transplant 2002, 2:674-677.
25. Calne R, Moffatt SD, Friend PJ, et al.: Campath 1H allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients. Transplantation 1999, 68:1613-1616.
26. Vincenti F, Monaco A, Grinyo J, et al.: Rapid steroid withdrawal versus standard steroid therapy in patients treated with basiliximab, cyclosporine, and mycophenolate mofetil for the prevention of acute rejection in renal transplantation. Transplant Proc 2001, 33:1011-1012.
27. Smiley ST, Csizmadia V, Gao W, et al.: Differential effects of cyclosporine A, methylprednisolone, mycophenolate mofetil, and rapamycin on CD154 induction and requirement for NFκB. Transplantation 2000, 70:415-419.
28. Grotz WH, Mundinger FA, Rasenack J, et al.: Bone loss after kidney transplantation: a longitudinal study in 115 graft recipients. Nephrol Dial Transplant 1995, 10:2096-2100.
29. Birkeland SA: Steroid-free immunosuppression in renal transplantation: a long-term follow-up of 100 consecutive patients. Transplantation 2001, 71:1089-1090.
30. Sarwal MM, Yorgin PD, Alexander S, et al.: Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. Transplantation 2001, 72:13-21.
31. Cole E, Landsberg D, Russell D, et al.: A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients. Transplantation 2001, 72:845-850.